Evidence map›Paper›PMID 42336841›Full record

ReviewNPJ Parkinson's disease2026

Primary prevention of Parkinson's disease: proceedings, the 8C's and a position statement from the Parkinson's disease prevention think tank.

Sneha Mantri, Rhoda Au, Anastasia Barnes, James C Beck, Kathleen Blake, Peggy Borum, Wendy Dahl, Briana de Miranda, E Ray Dorsey, Ruogu Fang and 21 more

Abstract readReview
In one paragraph

Review in NPJ Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Sneha MantriParkinson's Foundation, New York, NY, USA. smantri@parkinson.org.
Rhoda AuBoston University, Boston, MA, USA.
Anastasia BarnesUniversity of Florida, Gainesville, FL, USA.
James C BeckParkinson's Foundation, New York, NY, USA.
Kathleen BlakeParkinson's Foundation, New York, NY, USA.
Peggy BorumUniversity of Florida, Gainesville, FL, USA.
Wendy DahlUniversity of Florida, Gainesville, FL, USA.
Briana de MirandaUniversity of Alabama at Birmingham, Birmingham, AL, USA.
E Ray DorseyAtria Health and Research Institute, New York, NY, USA.
Ruogu FangUniversity of Florida, Gainesville, FL, USA.
J Daniel FennUniversity of Florida, Gainesville, FL, USA.
Sue J GoldieHarvard University, Cambridge, MA, USA.
Samuel M GoldmanUniversity of California at San Francisco, San Francisco, CA, USA.
Paulina Gonzalez-LatapiNorthwestern University, Chicago, IL, USA.
Diego L GuarinUniversity of Florida, Gainesville, FL, USA.
Brittany KryzyzanowskiBarrow Neurological Institute, Phoenix, AZ, USA.
Nicole LessardParkinson's Foundation, New York, NY, USA.
Andi Lipstein FristedtParkinson's Foundation, New York, NY, USA.
Tejas R MehtaUniversity of Florida, Gainesville, FL, USA.
Monica NorciniFresco Parkinson Institute Italia Onlus Foundation, Florence, Italy.
Jennifer L PurksUniversity of Florida, Gainesville, FL, USA.
Dawn SchiehserUniversity of Florida, Gainesville, FL, USA.
Michael A SchwarzschildMassachusetts General Hospital, Boston, MA, USA.
Caroline M TannerUniversity of California at San Francisco, San Francisco, CA, USA.
Alexis TemkinEnvironmental Working Group, Washington, DC, USA.
J Bryan UnruhUniversity of Florida, Gainesville, FL, USA.
Chris VulpeUniversity of Florida, Gainesville, FL, USA.
Kristin WallockParkinson's Foundation, New York, NY, USA.
Cordelia WalzParkinson's Foundation, New York, NY, USA.
Allison W WillisUniversity of Pennsylvania, Philadelphia, PA, USA.
Michael S OkunUniversity of Florida, Gainesville, FL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This Perspective outlines the challenges addressed at the first Annual Parkinson's Disease (PD) Prevention Think Tank, held on November 20-21, 2025 in Gainesville, Florida at the Fixel Institute. Over the course of two days, attendees from a wide variety of disciplines, including movement disorders neurology, environmental sciences, agriculture, public policy, public health, patient advocate groups, and more, discussed the current state of primary prevention research in PD, examined the lessons learned from prevention research in other disorders, and identified necessary regulatory and policy actions for moving toward primary prevention of PD. Eight key components of primary prevention are identified (8 C's): accurately Count incidence and prevalence, Conduct longitudinal cohort studies, induce policy Change, Counsel on individual behavior change, Communicate clearly with the general public and with key stakeholders, form multi-centric Coalitions across neurodegenerative disorders, apply Cross-disciplinary approaches, and provide sustained financial Commitment to support ongoing prevention and mitigation efforts. These proceedings serve as an initial call-to-action for at-risk individuals, the clinicians who care for them, and for policymakers.

Identifiers

PMID42336841
PMCPMC13639014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.